CME in Minutes: Education in Primary Care
Adam S. Wenick, MD, PhD - Keeping Sight of Adherence with VEGF-Targeted Therapy: Individualized Dosing Strategies to Improve Care for nAMD
02 Dec 2022
Please visit answersincme.com/AXS860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, Dr. Adam S. Wenick, an expert in ophthalmology, discusses treatment adherence in neovascular age-related macular degeneration (nAMD). Upon completion of this activity, participants should be better able to: Recognize the clinical impact of available intravitreal vascular endothelial growth factor– (VEGF-) targeted therapies for neovascular age-related macular degeneration (nAMD); Outline practical strategies to individualize intravitreal VEGF-targeted treatment selection and dosing for patients with nAMD; and Review patient counseling approaches to improve treatment adherence to intravitreal VEGF-targeted therapies for nAMD.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana